John Cameron;Sanela Bilic;Shailaja Kasibhatla;Danny Howard, JR.;Yong Jia
发明人:
Yong Jia,Shailaja Kasibhatla,Sanela Bilic,John Cameron,Danny Howard, JR.
申请号：
US15877436
公开号：
US20180177872A1
申请日:
2016.07.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising PD-1 antagonist and an EGFR Inhibitor. The present combination can be administered independently or separately, in a quantity which is jointly therapeutically effective for the treatment of cancer. The invention also provides the use of such a combination for the manufacture of a medicament； the use of such a combination as a medicine； a kit of part comprising such a combination； and a method of treatment of such a combination.
